Skip to Main Content

Author Details

Douglas A Lauffenburger
Massachusetts Institute of Technology
1979
557
102
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36669487Humoral signatures of MOG-antibody-associated disease track with age and disease activity.Cell Rep Med2023
37672567Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.Sci Transl Med2023
37734322What cannot be seen correctly in 2D visualizations of single-cell 'omics data?Cell Syst2023
38007686Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines.Cell Rep2023
37577655Humoral correlates of protection against <i>Mycobacterium tuberculosis</i> following intravenous Bacille Calmette-Guérin vaccination in rhesus macaques.bioRxiv2023
37473730Biphasic JNK-Erk signaling separates the induction and maintenance of cell senescence after DNA damage induced by topoisomerase II inhibition.Cell Syst2023
37149863Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling.Cell Rep2023
37267955Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques.Cell Host Microbe2023
36890168Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design.NPJ Vaccines2023
37200108Host genetic background is a barrier to broadly effective vaccine-mediated protection against tuberculosis.J Clin Invest2023
37322179ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.Nat Immunol2023
37061918Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.Cell Rep2023
36805331Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.JCI Insight2023
36692019Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.JCI Insight2023
37182520Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines.Cell Rep Med2023
36737667Author Correction: Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.Nat Biomed Eng2023
36922512Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.NPJ Vaccines2023
36669487Humoral signatures of MOG-antibody-associated disease track with age and disease activity.Cell Rep Med2023
37161609Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses.Brain2023
38007686Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines.Cell Rep2023
37577655Humoral correlates of protection against <i>Mycobacterium tuberculosis</i> following intravenous Bacille Calmette-Guérin vaccination in rhesus macaques.bioRxiv2023
37734322What cannot be seen correctly in 2D visualizations of single-cell 'omics data?Cell Syst2023
37672567Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.Sci Transl Med2023
37061918Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.Cell Rep2023
37322179ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.Nat Immunol2023
37149863Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling.Cell Rep2023
37182520Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines.Cell Rep Med2023
37267955Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques.Cell Host Microbe2023
37200108Host genetic background is a barrier to broadly effective vaccine-mediated protection against tuberculosis.J Clin Invest2023
37473730Biphasic JNK-Erk signaling separates the induction and maintenance of cell senescence after DNA damage induced by topoisomerase II inhibition.Cell Syst2023
37161609Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses.Brain2023
36890168Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design.NPJ Vaccines2023
36922512Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.NPJ Vaccines2023
36692019Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.JCI Insight2023
36805331Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.JCI Insight2023
36737667Author Correction: Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.Nat Biomed Eng2023
34737186Regulatory T Cells Control Effector T Cell Inflammation in Human Prediabetes.Diabetes2022
35710755Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.Nat Biomed Eng2022
35654811Artificial neural networks enable genome-scale simulations of intracellular signaling.Nat Commun2022
35767652Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection.Sci Transl Med2022
35762593The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.mBio2022
35512013Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.PLoS Biol2022
36351430Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy.Cell Rep Med2022
36000735Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.mBio2022
35934070A multifaceted high-throughput assay for probing antigen-specific antibody-mediated primary monocyte phagocytosis and downstream functions.J Immunol Methods2022
35990702An affinity for brainstem microglia in pediatric high-grade gliomas of brainstem origin.Neurooncol Adv2022
35417540Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection.J Infect Dis2022
36056073Selective transfer of maternal antibodies in preterm and fullterm children.Sci Rep2022
35669012Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomas.Neurooncol Adv2022
35600339Cancer-Associated Fibroblasts and Squamous Epithelial Cells Constitute a Unique Microenvironment in a Mouse Model of Inflammation-Induced Colon Cancer.Front Oncol2022
  • 1 - 50 of 1,114

Recommended Authors

Koichi Takahashi
RIKEN Center for Biosystems Dynamics Research
Career Start Year 2010
Number of shared co-authors 0
Matt Thomson
California Institute of Technology
Career Start Year 2009
Number of shared co-authors 1
Marc R Birtwistle
Clemson University.
Career Start Year 2007
Number of shared co-authors 5
Laura M Heiser
Oregon Health Sciences University
Career Start Year 2005
Number of shared co-authors 4
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 3
Amina A Qutub
University of Texas at San Antonio
Career Start Year 2004
Number of shared co-authors 1
Jerry S H Lee
University of Southern California
Career Start Year 2004
Number of shared co-authors 0
Prisca Liberali
Friedrich Miescher Institute for Biomedical Imaging
Career Start Year 2003
Number of shared co-authors 4
Hon S Leong
University of Toronto
Career Start Year 2002
Number of shared co-authors 0
Lani F Wu
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2001
Number of shared co-authors 0
Steven J Altschuler
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2001
Number of shared co-authors 0
Ilya Shmulevich
Institute for Systems Biology
Career Start Year 2001
Number of shared co-authors 1
Vineet Gupta
Purdue University
Career Start Year 1999
Number of shared co-authors 0
Val??rie Petit
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Career Start Year 1999
Number of shared co-authors 0
Gregory A Gibson
University of Pittsburgh
Career Start Year 1999
Number of shared co-authors 1
Lucas Pelkmans
University of Zurich
Career Start Year 1999
Number of shared co-authors 4
Roland Eils
Berlin Institute of Health (BIH) and Charite
Career Start Year 1995
Number of shared co-authors 6
Karen H Martin
West Virginia University Cancer Institute, West Virginia University
Career Start Year 1993
Number of shared co-authors 0
Johnathon N Lakins
University of California san francisco
Career Start Year 1992
Number of shared co-authors 1
Donna J Webb
Vanderbilt University
Career Start Year 1991
Number of shared co-authors 1
Zolt??n N Oltvai
University of Rochester
Career Start Year 1991
Number of shared co-authors 0
Gustavo Stolovitzky
IBM T.J. Watson Research Center
Career Start Year 1990
Number of shared co-authors 5
Shankar Subramaniam
University of California
Career Start Year 1989
Number of shared co-authors 3
Anne L Plant
National Institute of Standards and Technology
Career Start Year 1983
Number of shared co-authors 3
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Peter J Munson
and Blood Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 0
Karin D Rodland
Oregon Health and Science University
Career Start Year 1973
Number of shared co-authors 4
Cindy A Hunt
University of California san francisco
Career Start Year 1973
Number of shared co-authors 0
Edouard C Nice
Monash University
Career Start Year 1971
Number of shared co-authors 3
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 2

Collaborators

Galit Alter
Co-authored papers 75
H S Wiley
Co-authored papers 32
Peter K Sorger
Co-authored papers 31
Stephanie Fischinger
Co-authored papers 26
Forest M White
Massachusetts Institute of Technology
Co-authored papers 19
Todd J Suscovich
Co-authored papers 19
Dan H Barouch
Co-authored papers 18
Kevin A Janes
University of Virginia
Co-authored papers 14
Julio Saez-Rodriguez
Institute of Computational Biomedicine, Heidelberg University
Co-authored papers 14
Matthew J Gorman
Co-authored papers 14
Alan Rick Horwitz
Allen Institute for Cell Science
Co-authored papers 13
Hendrik Streeck
Co-authored papers 11
Jishnu Das
Co-authored papers 11
Wen-Han Yu
Co-authored papers 10
Shannon K Alford
National Cancer Institute
Co-authored papers 9
Lee K Opresko
Co-authored papers 9
Ken S Lau
Vanderbilt University School of Medicine
Co-authored papers 8
Andrea G Edlow
Co-authored papers 8
Peter W Zandstra
Co-authored papers 6
Michael S Seaman
Co-authored papers 6
Richelle C Charles
Massachusetts General Hospital
Co-authored papers 6
Alejandro Wolf-Yadlin
University of Washington
Co-authored papers 5
Bree B Aldridge
Tufts University School of Engineering
Co-authored papers 5
George Q Daley
Boston Children's Hospital, Harvard Medical School
Co-authored papers 5
Ernest Fraenkel
Co-authored papers 5
Edward T Ryan
Massachusetts General Hospital
Co-authored papers 5
Marcus Altfeld
Co-authored papers 5
Leona D Samson
Massachusetts Institute of Technology
Co-authored papers 4
David V Schaffer
University of California berkeley
Co-authored papers 4
Yongfei Cai
Co-authored papers 4
Release 1.2